SYDNEY (Reuters) – Australia’s first initial public offering in a medicinal marijuana company is three times oversubscribed, giving high hopes to its … …read more
SYDNEY (Reuters) – Australia’s first initial public offering in a medicinal marijuana company is three times oversubscribed, giving high hopes to its … …read more